DMD and type 2 diabetes mellitus: Furthermore, a general applicability of ML is demonstrated through designing synthetically accessible antisense PNA sequences from 102 315 predicted candidates targeting exon 44 of the human dystrophin gene, SARS‐CoV‐2, HIV, as well as selected genes associated with cardiovascular diseases, type II diabetes, and various cancers.